Welcome to our dedicated page for McEwen SEC filings (Ticker: MUX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The McEwen Inc. (MUX) SEC filings page on Stock Titan provides direct access to the company’s U.S. regulatory disclosures, together with AI-assisted summaries to help interpret complex documents. As a Colorado corporation listed on the New York Stock Exchange, McEwen files current reports on Form 8-K and other periodic reports that describe material events affecting its gold, silver and copper business across the Americas.
In recent Form 8-K filings, McEwen has reported on a range of topics, including the business combination with Canadian Gold Corp. that added the Tartan Mine Project in Manitoba, the extension of the Environmental Impact Assessment for the El Gallo Mine in Mexico, and strategic investments such as the share exchange agreement to acquire an interest in Paragon Geochemical Laboratories. Other 8-Ks discuss financing transactions like flow-through share offerings, appointments of senior executives, and technical and feasibility milestones at the Los Azules copper project in San Juan, Argentina.
Through this page, users can review McEwen’s filings to see how the company describes its operations at the Gold Bar Mine Complex in Nevada, the Fox Complex in Ontario, the San José Mine in Argentina, the El Gallo Mine in Mexico and its 46.4% interest in McEwen Copper. AI-powered tools highlight key sections of lengthy filings, such as risk factor discussions, descriptions of material agreements, and summaries of technical and permitting developments.
Investors researching MUX can use the filings page to locate quarterly and annual reports when available (Forms 10-Q and 10-K), current reports on Form 8-K, and exhibits referenced in those filings. The inclusion of insider and financing-related disclosures, where filed, helps users understand equity issuances, ownership changes and other regulatory events that may influence the company’s capital structure and project funding.
McEwen Inc. officer reports accelerated RSU vesting and cash settlement. A company officer, listed as VP Corporate Development, reported activity in restricted stock units tied to McEwen Inc. common stock. One RSU grant made on August 11, 2025 had its vesting schedule amended so the second vesting event moved from December 28, 2025 to December 20, 2025, causing 1,200 units to vest and be settled entirely in cash on that date, with remaining units scheduled to vest on June 28, 2026. A second RSU grant made on September 8, 2025 was amended in the same way, leading to 500 units vesting and being settled for cash on December 20, 2025, with the balance also scheduled to vest on June 28, 2026. Each RSU represents a contingent right to receive one share of common stock or its cash value, at the discretion of the board committee.
McEwen Inc. director and Chief Operating Officer William M. Shaver reported the vesting of several restricted stock unit awards and related acquisitions of common shares. On December 20, 2025, restricted stock units granted on June 29, 2025 vested as to 11,740 shares, those granted on November 10, 2025 vested as to 5,700 shares, and earlier grants from August 11, 2025 and September 8, 2025 vested as to 2,100 and 867 shares, respectively. Each unit converts into one share of common stock or its cash value at the discretion of the company’s Compensation, Nominating & Corporate Governance Committee.
Following these transactions, Shaver directly owned 149,200 shares of McEwen Inc. common stock. The remaining portions of these awards are scheduled to vest on specified future dates in 2026 according to each grant’s vesting schedule.
McEwen Inc. disclosed an unregistered equity financing and a pending share issuance tied to a prior agreement. The company entered into definitive agreements to sell 565,000 shares of common stock as flow-through shares under Canadian tax rules, split between 215,000 Canadian Exploration Expense shares at US$23.80 and 350,000 Canadian Development Expense shares at US$20.90. The exploration tranche closed on December 19, 2025, while the development tranche is expected to close in January 2026, generating approximately $12.4 million in net proceeds for exploration and development work.
McEwen also describes a Share Exchange Agreement with Britannia Life Sciences Inc., under which it must issue additional common shares valued at CAD$11,340,035, calculated using a 20-day volume-weighted average price and a Bank of Canada exchange rate. Both the flow-through Offering and the Payment Shares rely on private-offering exemptions from U.S. registration, including Section 4(a)(2), Regulation D, and Regulation S.
McEwen Inc. (MUX) reported insider equity activity by its VP Corporate Development. On November 10, 2025, the officer acquired a total of 790 shares of common stock through conversions of restricted stock units, increasing his directly held stake to 4,604 shares.
These transactions came from vesting of two restricted stock unit awards originally granted on August 11, 2025 and September 8, 2025. For the first award, 1,200 units vested on November 10, 2025, with 642 shares settling in cash and the rest in stock, and the remaining units vest in two equal installments on December 28, 2025 and June 28, 2026. For the second award, 500 units vested on November 10, 2025, with 268 shares settling in cash, and the balance vesting on the same two future dates.
McEwen Inc. (MUX) officer Stephan Michael Spears, VP Corporate Development, reported an option exercise and share sale involving the company’s common stock. On 09/19/2025, he exercised 12,600 stock options at an exercise price of $1.25 per share and acquired the same number of common shares. That same day, he disposed of 12,600 common shares in an open-market sale at a weighted average price of $14.3477 per share, with individual trades ranging from $13.71 to $14.65. Following these transactions, Spears beneficially owned 3,814 shares of McEwen common stock directly. The filing notes that the reported option was granted in 2020, vested in three equal annual installments beginning on September 29, 2021, and was nearing its September 28, 2025 expiration date, with figures adjusted for McEwen’s 10-for-1 reverse stock split effective July 28, 2022.
McEwen Inc. (MUX) Form 4: Chief Operating Officer and Director William M. Shaver reported RSU-related transactions on November 10, 2025. Two tranches of restricted stock units vested and were settled into common stock: 2,100 shares and 867 shares via code M. Following these, his directly held common stock was 128,793 shares.
On the same date, he received a new award of 17,100 restricted stock units at $0 price. Footnotes detail prior grants on August 11, 2025 and September 8, 2025, with remaining RSU vesting scheduled in equal installments on December 28, 2025 and June 28, 2026; the new 17,100-unit award vests in three equal installments on December 20, 2025, June 29, 2026, and December 20, 2026.
McEwen Inc. (MUX) filed a Form 4 disclosing CFO Perry Ing’s equity activity. On November 10, 2025, restricted stock units (RSUs) vested and partially settled in cash, resulting in stock deliveries of 867 shares and 372 shares.
The 1,868 RSUs granted on August 11, 2025 vested as to 1,868 shares on November 10, 2025, of which 1,001 shares settled for cash. The 800 RSUs granted on September 8, 2025 vested as to 800 shares on November 10, 2025, of which 428 shares settled for cash. Following these transactions, common shares beneficially owned were 42,069 (direct).
Ing also received a new award of 6,990 RSUs on November 10, 2025. These will vest in three equal installments on December 20, 2025, June 29, 2026 and December 20, 2026. Remaining portions of the August 11 and September 8 RSU grants are scheduled to vest in equal installments on December 28, 2025 and June 28, 2026.
McEwen Inc. (MUX) filed a Form 4 disclosing a director transaction. On 11/10/2025, the reporting person acquired 585 deferred stock units (DSUs) at $0. Each DSU represents one share of common stock and is fully vested. Delivery occurs upon the director’s termination of continuous service from the Board, with an option to defer delivery. Following the transaction, the director beneficially owned 1,311 derivative securities.
McEwen Inc. (MUX) reported insider equity changes by its VP - Finance. On November 10, 2025, restricted stock units (RSUs) vested from two grants: 1,268 RSUs from an August 11, 2025 award (with 680 shares settling for cash) and 534 RSUs from a September 8, 2025 award (with 286 shares settling for cash).
Table I shows code M conversions resulting in acquisitions of common stock: 588 shares and 248 shares. The remaining RSUs from both grants are scheduled to vest in two equal installments on December 28, 2025 and June 28, 2026.
McEwen Inc. (MUX) reported a director equity grant on 11/10/2025. The filing shows an award of 50,000 stock options at an exercise price of $17.09, expiring on 11/10/2030. These options vest in three equal annual installments beginning on November 10, 2026.
The director also received 930 restricted stock units (RSUs). Each RSU represents the right to receive one share of common stock, or the cash value per the award agreement at the Compensation, Nominating & Corporate Governance Committee’s discretion. The RSUs vest in three installments on December 20, 2025, June 29, 2026, and December 20, 2026.